These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10465321)

  • 1. Changing patterns of coronary heart disease in the hunter region of New South Wales, Australia.
    Dobson AJ; McElduff P; Heller R; Alexander H; Colley P; D'Este K
    J Clin Epidemiol; 1999 Aug; 52(8):761-71. PubMed ID: 10465321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in coronary heart disease--has the socio-economic differential changed?
    McElduff P; Dobson AJ
    Aust N Z J Public Health; 2000 Oct; 24(5):465-73. PubMed ID: 11109682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary events in the Hunter region of New South Wales, Australia: 1984-1986.
    Dobson AJ; Alexander HM; Al-Roomi K; Gibberd RW; Heller RF; Leeder SR; Lloyd DM; Malcolm JA; Steele PL
    Acta Med Scand Suppl; 1988; 728():84-9. PubMed ID: 3202036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study.
    Vittinghoff E; Shlipak MG; Varosy PD; Furberg CD; Ireland CC; Khan SS; Blumenthal R; Barrett-Connor E; Hulley S;
    Ann Intern Med; 2003 Jan; 138(2):81-9. PubMed ID: 12529088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESC Population Studies Lecture 1996. Cardiovascular monitoring of a city over 30 years.
    Wilhelmsen L
    Eur Heart J; 1997 Aug; 18(8):1220-30. PubMed ID: 9458414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991. Presentation, diagnosis, treatment, and 28-day case fatality of 3991 events in men and 1551 events in women.
    Tunstall-Pedoe H; Morrison C; Woodward M; Fitzpatrick B; Watt G
    Circulation; 1996 Jun; 93(11):1981-92. PubMed ID: 8640972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in drug treatment and case fatality of patients with acute myocardial infarction. Observations from the Newcastle MONICA Project, 1984/1985 to 1988/1990.
    Heller RF; Dobson AJ; Alexander HM; Steele PL; Malcolm JA
    Med J Aust; 1992 Jul; 157(2):83-6. PubMed ID: 1630395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in ischaemic heart disease in the Hunter Region of New South Wales 1985-1989.
    Dobson AJ; Alexander HM; Heller RF; Malcolm JA; Steele PL
    Med J Aust; 1991 Nov; 155(9):599, 602-4, 608. PubMed ID: 1943957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease.
    Peterson JG; Topol EJ; Sapp SK; Young JB; Lincoff AM; Lauer MS
    Am J Med; 2000 Oct; 109(5):371-7. PubMed ID: 11020393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994.
    Rosamond WD; Chambless LE; Folsom AR; Cooper LS; Conwill DE; Clegg L; Wang CH; Heiss G
    N Engl J Med; 1998 Sep; 339(13):861-7. PubMed ID: 9744969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.
    Sanmuganathan PS; Ghahramani P; Jackson PR; Wallis EJ; Ramsay LE
    Heart; 2001 Mar; 85(3):265-71. PubMed ID: 11179262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic heart disease in the Hunter Region of New South Wales, Australia, 1979-1985.
    Dobson AJ; Gibberd RW; Leeder SR; Alexander HM; Young AF; Lloyd DM
    Am J Epidemiol; 1988 Jul; 128(1):106-15. PubMed ID: 3381819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in CHD mortality, morbidity and risk factor levels from 1960 to 1986: the Minnesota Heart Survey.
    Burke GL; Sprafka JM; Folsom AR; Luepker RV; Norsted SW; Blackburn H
    Int J Epidemiol; 1989; 18(3 Suppl 1):S73-81. PubMed ID: 2807710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.
    McGovern PG; Pankow JS; Shahar E; Doliszny KM; Folsom AR; Blackburn H; Luepker RV
    N Engl J Med; 1996 Apr; 334(14):884-90. PubMed ID: 8596571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking and the incidence of coronary heart disease in an Australian population.
    Chun BY; Dobson AJ; Heller RF
    Med J Aust; 1993 Oct; 159(8):508-12. PubMed ID: 8412948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Declining rates of coronary heart disease in New Zealand and Australia, 1983-1993.
    Beaglehole R; Stewart AW; Jackson R; Dobson AJ; McElduff P; D'Este K; Heller RF; Jamrozik KD; Hobbs MS; Parsons R; Broadhurst R
    Am J Epidemiol; 1997 Apr; 145(8):707-13. PubMed ID: 9125997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary event and case fatality rates in an English population: results of the Oxford myocardial infarction incidence study. The Oxford Myocardial Infarction Incidence Study Group.
    Volmink JA; Newton JN; Hicks NR; Sleight P; Fowler GH; Neil HA
    Heart; 1998 Jul; 80(1):40-4. PubMed ID: 9764057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Socio-economic, migrant and geographic differentials in coronary heart disease occurrence in New South Wales.
    Taylor R; Chey T; Bauman A; Webster I
    Aust N Z J Public Health; 1999 Feb; 23(1):20-6. PubMed ID: 10083685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.
    EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
    Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.